In an in-vitro test (i.e. in a petri dish), the researchers saw that both CoV2-biRN antibodies retained their ability to neutralize multiple variants of the COVID-19 virus.

Researchers have discovered a strategy to neutralize two highly lethal viruses for which there is currently no approved vaccine or cure.

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple COVID-19 variants.

The study shows that binding of a neutralizing antibody to a specific rhinovirus causes significant changes around holes in the shell of the virus, allowing the viral RNA to escape. This “uncoating” ...

Prevention quotes Thomas Russo in an article about protecting yourself from norovirus. When using disinfectants on surfaces, Russo says that “Norovirus is not inactivated by alcohol.” He points out ...